Arrhythmia and sudden death associated with elevated cardiac chloride channel activity

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 11, 2011, Pages 2307-2316

  Ye, L ^a,b,e   Zhu, W ^a,f   Backx, P H ^b,c   Cortez, M A ^a,d   Wu, J ^a   Chow, Y H ^a,b,g   Mckerlie, C ^a,b   Wang, A ^a   Tsui, L C ^a,d,h   Gross, G J ^a,d   Hu, J ^a,b,d  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^g UNIVERSITY OF WASHINGTON   (United States)

^h UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

CAMP; Cardiac arrhythmia; Chloride channel; Stress hormone; Sudden death

Indexed keywords

CHLORIDE CHANNEL; ISOPRENALINE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL; ARTICLE; ATRIOVENTRICULAR BLOCK; BIOSYNTHESIS; BRADYCARDIA; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; GENETICS; HEART; HEART ARRHYTHMIA; HEART ATRIOVENTRICULAR NODE; HEART MUSCLE; HEART MUSCLE CONDUCTION SYSTEM; HEART PACING; HEART VENTRICLE TACHYCARDIA; IN SITU HYBRIDIZATION; METABOLISM; MOUSE; PATHOPHYSIOLOGY; SUDDEN DEATH; TRANSGENIC MOUSE;

ANIMALS; ARRHYTHMIAS, CARDIAC; ATRIOVENTRICULAR BLOCK; ATRIOVENTRICULAR NODE; BRADYCARDIA; CARDIAC PACING, ARTIFICIAL; CHLORIDE CHANNELS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DEATH, SUDDEN, CARDIAC; HEART; HEART CONDUCTION SYSTEM; IN SITU HYBRIDIZATION; ISOPROTERENOL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOCARDIUM; TACHYCARDIA, VENTRICULAR;

MUS; MUS MUSCULUS;

EID: 80054914585     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01243.x     Document Type: Article

References (50)

1. Tomaselli GF, Zipes DP. What causes sudden death in heart failure? Circ Res. 2004; 95: 754-63.
2. Keating MT, Sanguinetti MC. Molecular and cellular mechanisms of cardiac arrhythmias. Cell. 2001; 104: 569-80.
3. Robbins J, Dorn GW, 2nd. Listening for hoof beats in heart beats. Nat Med. 2000; 6: 968-70.
4. Kanagaratnam P, Dupont E, Rothery S, et al. Human atrial conduction and arrhythmogenesis correlates with conformational exposure of specific epitopes on the connexin40 carboxyl tail. J Mol Cell Cardiol. 2006; 40: 675-87.
5. Dupont E, Ko Y, Rothery S, et al. The gap-junctional protein connexin40 is elevated in patients susceptible to postoperative atrial fibrillation. Circulation. 2001; 103: 842-9.
6. Bevilacqua LM, Simon AM, Maguire CT, et al. A targeted disruption in connexin40 leads to distinct atrioventricular conduction defects. J Interv Card Electrophysiol. 2000; 4: 459-67.
7. Hagendorff A, Schumacher B, Kirchhoff S, et al. Conduction disturbances and increased atrial vulnerability in Connexin40-deficient mice analyzed by transesophageal stimulation. Circulation. 1999; 99: 1508-15.
8. Bahinski A, Nairn AC, Greengard P, et al. Chloride conductance regulated by cyclic AMP-dependent protein kinase in cardiac myocytes. Nature. 1989; 340: 718-21.
9. Harvey RD, Hume JR. Autonomic regulation of a chloride current in heart. Science. 1989; 244: 983-5.
10. Hagiwara N, Masuda H, Shoda M, et al. Stretch-activated anion currents of rabbit cardiac myocytes. J Physiol. 1992; 456: 285-302.
11. Verkerk AO, Veldkamp MW, Bouman LN, et al. Calcium-activated Cl(-) current contributes to delayed afterdepolarizations in single Purkinje and ventricular myocytes. Circulation. 2000; 101: 2639-44.
12. Zygmunt AC. Intracellular calcium activates a chloride current in canine ventricular myocytes. Am J Physiol. 1994; 267: H1984-95.
13. Zygmunt AC, Gibbons WR. Calcium-activated chloride current in rabbit ventricular myocytes. Circ Res. 1991; 68: 424-37.
14. Zygmunt AC, Gibbons WR. Properties of the calcium-activated chloride current in heart. J Gen Physiol. 1992; 99: 391-414.
15. Sorota S. Swelling-induced chloride-sensitive current in canine atrial cells revealed by whole-cell patch-clamp method. Circ Res. 1992; 70: 679-87.
16. Hiraoka M, Kawano S, Hirano Y, et al. Role of cardiac chloride currents in changes in action potential characteristics and arrhythmias. Cardiovasc Res. 1998; 40: 23-33.
17. Hart P, Warth JD, Levesque PC, et al. Cystic fibrosis gene encodes a cAMP-dependent chloride channel in heart. Proc Natl Acad Sci USA. 1996; 93: 6343-8.
18. Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989; 245: 1066-73.
19. Horowitz B, Tsung SS, Hart P, et al. Alternative splicing of CFTR Cl- channels in heart. Am J Physiol. 1993; 264: H2214-20.
20. Nagel G, Hwang TC, Nastiuk KL, et al. The protein kinase A-regulated cardiac Cl- channel resembles the cystic fibrosis transmembrane conductance regulator. Nature. 1992; 360: 81-4.
21. Warth JD, Collier ML, Hart P, et al. CFTR chloride channels in human and simian heart. Cardiovasc Res. 1996; 31: 615-24.
22. Yajima T, Nagashima H, Tsutsumi-Sakai R, et al. Functional activity of the CFTR Cl- channel in human myocardium. Heart Vessels. 1997; 12: 255-61.
23. Duan D, Ye L, Britton F, et al. Purinoceptor-coupled Cl- channels in mouse heart: a novel, alternative pathway for CFTR regulation. J Physiol. 1999; 521: 43-56.
24. Lader AS, Wang Y, Jackson GR Jr, et al. cAMP-activated anion conductance is associated with expression of CFTR in neonatal mouse cardiac myocytes. Am J Physiol Cell Physiol. 2000; 278: C436-50.
25. Wong KR, Trezise AE, Bryant S, et al. Molecular and functional distributions of chloride conductances in rabbit ventricle. Am J Physiol. 1999; 277: H1403-9.
26. Wong KR, Trezise AE, Vandenberg JI. Developmental regulation of the gradient of cftr expression in the rabbit heart. Mech Dev. 2000; 94: 195-7.
27. Chen H, Liu LL, Ye LL, et al. Targeted inactivation of cystic fibrosis transmembrane conductance regulator chloride channel gene prevents ischemic preconditioning in isolated mouse heart. Circulation. 2004; 110: 700-4.
28. Fabritz L, Kirchhof P, Fortmuller L, et al. Gene dose-dependent atrial arrhythmias, heart block, and brady-cardiomyopathy in mice overexpressing A(3) adenosine receptors. Cardiovasc Res. 2004; 62: 500-8.
29. Gauthier NS, Headrick JP, Matherne GP. Myocardial function in the working mouse heart overexpressing cardiac A1 adenosine receptors. J Mol Cell Cardiol. 1998; 30: 187-93.
30. Headrick JP, Gauthier NS, Morrison R, et al. Cardioprotection by K(ATP) channels in wild-type hearts and hearts overexpressing A(1)-adenosine receptors. Am J Physiol Heart Circ Physiol. 2000; 279: H1690-7.
31. Kirchhof P, Fabritz L, Fortmuller L, et al. Altered sinus nodal and atrioventricular nodal function in freely moving mice overexpressing the A1 adenosine receptor. Am J Physiol Heart Circ Physiol. 2003; 285: H145-53.
32. Matherne GP, Linden J, Byford AM, et al. Transgenic A1 adenosine receptor overexpression increases myocardial resistance to ischemia. Proc Natl Acad Sci USA. 1997; 94: 6541-6.
33. Neumann J, Boknik P, Begrow F, et al. Altered signal transduction in cardiac ventricle overexpressing A(1)-adenosine receptors. Cardiovasc Res. 2003; 60: 529-37.
34. Ye L, Chan S, Chow YH, et al. Regulated expression of the human CFTR gene in epithelial cells. Mol Ther. 2001; 3: 723-33.
35. Chow YH, O'Brodovich H, Plumb J, et al. Development of an epithelium-specific expression cassette with human DNA regulatory elements for transgene expression in lung airways. Proc Natl Acad Sci USA. 1997; 94: 14695-700.
36. Zhu W, Lepore JJ, Saba S, et al. Cardiac electrophysiologic abnormalities in the CREBA133 transgenic mouse model of idiopathic dilated cardiomyopathy. J Cardiovasc Electrophysiol. 2003; 14: 982-9.
37. Erlenkamp S, Glitsch HG, Kockskamper J. Dual regulation of cardiac Na+-K+ pumps and CFTR Cl- channels by protein kinases A and C. Pflugers Arch. 2002; 444: 251-62.
38. Shuba LM, Missan S, Zhabyeyev P, et al. Selective block of swelling-activated Cl- channels over cAMP-dependent Cl- channels in ventricular myocytes. Eur J Pharmacol. 2004; 491: 111-20.
39. Yamamoto-Mizuma S, Wang GX, Hume JR. P2Y purinergic receptor regulation of CFTR chloride channels in mouse cardiac myocytes. J Physiol. 2004; 556: 727-37.
40. Martynyuk AE, Seubert CN, Zima A, et al. Contribution of I(K, ADO) to the negative dromotropic effect of adenosine. Basic Res Cardiol. 2002; 97: 286-94.
41. Duan DY, Liu LL, Bozeat N, et al. Functional role of anion channels in cardiac diseases. Acta Pharmacol Sin. 2005; 26: 265-78.
42. Deane R, Chummun H, Prashad D. Differences in urinary stress hormones in male and female nurses at different ages. J Adv Nurs. 2002; 37: 304-10.
43. Gaillard RC, Spinedi E. Sex- and stress-steroids interactions and the immune system: evidence for a neuroendocrine-immunological sexual dimorphism. Domest Anim Endocrinol. 1998; 15: 345-52.
44. Litschauer B, Zauchner S, Huemer KH, et al. Cardiovascular, endocrine, and receptor measures as related to sex and menstrual cycle phase. Psychosom Med. 1998; 60: 219-26.
45. Patchev VK, Almeida OF. Gender specificity in the neural regulation of the response to stress: new leads from classical paradigms. Mol Neurobiol. 1998; 16: 63-77.
46. Faulx MD, Ernsberger P, Vatner D, et al. Strain-dependent beta-adrenergic receptor function influences myocardial responses to isoproterenol stimulation in mice. Am J Physiol Heart Circ Physiol. 2005; 289: H30-6.
47. Hohimer AR, Davis LE, Hatton DC. Repeated daily injections and osmotic pump infusion of isoproterenol cause similar increases in cardiac mass but have different effects on blood pressure. Can J Physiol Pharmacol. 2005; 83: 191-7.
48. Kotsias BA, Peracchia C. Functional interaction between CFTR and Cx45 gap junction channels expressed in oocytes. J Membr Biol. 2005; 203: 143-50.
49. Schwiebert EM, Benos DJ, Egan ME, et al. CFTR is a conductance regulator as well as a chloride channel. Physiol Rev. 1999; 79: S145-66.
50. Brembilla-Perrot B, Muhanna I, Nippert M, et al. Paradoxical effect of isoprenaline infusion. Europace. 2005; 7: 621-7.